| Product Code: ETC13129642 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Non-Hodgkin Lymphoma Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 Africa Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.8 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.9 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.11 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.12 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.12 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Africa Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 Africa Non-Hodgkin Lymphoma Diagnostics Market, 2021 - 2031 |
6.1 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.1.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.1.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Immunohistochemistry, 2021 - 2031 |
6.1.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Biomarker Test, 2021 - 2031 |
6.1.6 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Genetic Test, 2021 - 2031 |
6.1.7 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cytogenetics, 2021 - 2031 |
6.1.8 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Lumbar Puncture (Spinal Tap), 2021 - 2031 |
6.1.9 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage 0, 2021 - 2031 |
6.2.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage I, 2021 - 2031 |
6.2.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage Ii, 2021 - 2031 |
6.2.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage Iii, 2021 - 2031 |
6.2.6 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Stage Iv, 2021 - 2031 |
6.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Aggressive Lymphomas, 2021 - 2031 |
6.3.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Indolent Lymphomas, 2021 - 2031 |
6.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Instrument Based Products, 2021 - 2031 |
6.4.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Platform Based Products, 2021 - 2031 |
6.4.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Kits And Reagents, 2021 - 2031 |
6.4.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Other Consumables, 2021 - 2031 |
6.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Fluorescent In Situ Hybridization, 2021 - 2031 |
6.5.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Next Generation Sequencing, 2021 - 2031 |
6.5.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Fluorimmunoassay, 2021 - 2031 |
6.5.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Comparative Genomic Hybridization, 2021 - 2031 |
6.5.6 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Immunohistochemical, 2021 - 2031 |
6.5.7 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Screening, 2021 - 2031 |
6.6.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Diagnostic And Predictive, 2021 - 2031 |
6.6.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Prognostic, 2021 - 2031 |
6.6.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Research, 2021 - 2031 |
6.7 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.7.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.7.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Research Centers, 2021 - 2031 |
6.7.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Academic Institutes, 2021 - 2031 |
6.7.6 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.7.7 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.8 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.8.3 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
6.8.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa Non-Hodgkin Lymphoma Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
7.3.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.3.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.3.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.3.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Cancer Stage, 2021 - 2031 |
7.4 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.4.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Tumor Type, 2021 - 2031 |
7.5 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.6 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.7 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.8 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.9 Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.1 South Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.2 Egypt Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.3 Nigeria Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.9.4 Rest of Africa Non-Hodgkin Lymphoma Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Africa Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
9 Africa Non-Hodgkin Lymphoma Diagnostics Market - Export/Import By Countries Assessment |
10 Africa Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
10.1 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
10.4 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
10.5 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10.6 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.7 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.8 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10.9 Africa Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Africa Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
11.1 Africa Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 Africa Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here